2seventy bio, Inc. (NASDAQ:TSVT) Receives Consensus Rating of “Moderate Buy” from Analysts
2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) has been given an average rating of “Moderate Buy” by the nine research firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, four have given a buy rating and one […]
More Stories
3,200 Percent Increase in Vehicular Attacks Against ICE Officers: DHS
By Naveen Athrappully U.S. Immigration and Customs Enforcement personnel have faced more than a 1,300 percent increase in assaults and...
Rio Tinto in Talks to Buy Glencore in Potential Mega-Merger
By Evgenia Filimianova Rio Tinto is in early discussions to buy rival Glencore, the two companies said this week, a...
Trump Says US Will Begin Land Strikes on Cartels in Mexico
By Joseph Lord and Kimberly Hayek President Donald Trump announced in an interview aired Jan. 8 that the United States...
Argentina Repays $20 Billion US Swap Line, Bessent Says
By Andrew Moran Treasury Secretary Scott Bessent said on Jan. 9 that Argentina has repaid a drawdown on the $20...
US Economy Posts Modest Job Gains in December
By Andrew Moran U.S. payrolls climbed less than expected in December, while the unemployment rate came in below market estimates,...
US Trade Deficit Narrows Sharply to Lowest Level Since 2009
By Andrew Moran The U.S. trade deficit narrowed sharply in October 2025, falling to its lowest level in 16 years,...